FDA Poised to Make Impact on Underrepresented Populations in Clinical Studies
H1 Blog
JULY 30, 2024
We’re curious to see what will happen over the next 12 months and how pharma companies will respond.” Find out more by requesting a demo today. “Now, we’re at a place where the rubber is going to meet the road with the FDA reviewers, and we’ll see if they’re going to enforce this new guidance.
Let's personalize your content